{"id":56901,"date":"2021-03-04T17:18:37","date_gmt":"2021-03-04T16:18:37","guid":{"rendered":"https:\/\/www.fedaiisf.it\/?p=56901"},"modified":"2021-03-05T19:26:48","modified_gmt":"2021-03-05T18:26:48","slug":"apss-trento-proroga-della-sospensione-degli-incontri-da-parte-degli-informatori-scientifici-del-farmaco","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/apss-trento-proroga-della-sospensione-degli-incontri-da-parte-degli-informatori-scientifici-del-farmaco\/","title":{"rendered":"APSS Trento. Extension of the suspension of the meetings by the Scientific Representatives of the drug"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-large wp-image-56902\" src=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/03\/APSS-Trento-ISF-1024x551.jpeg\" alt=\"\" width=\"1024\" height=\"551\" srcset=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/03\/APSS-Trento-ISF-1024x551.jpeg 1024w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/03\/APSS-Trento-ISF-300x161.jpeg 300w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/03\/APSS-Trento-ISF-768x413.jpeg 768w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/03\/APSS-Trento-ISF.jpeg 1216w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-large wp-image-56903\" src=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/03\/APSS-Trento-oggetto-1024x293.jpeg\" alt=\"\" width=\"1024\" height=\"293\" srcset=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/03\/APSS-Trento-oggetto-1024x293.jpeg 1024w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/03\/APSS-Trento-oggetto-300x86.jpeg 300w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/03\/APSS-Trento-oggetto-768x220.jpeg 768w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/03\/APSS-Trento-oggetto.jpeg 1060w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/p>\n<div>\n<p style=\"text-align: justify;\"><span style=\"font-family: 'times new roman', times, serif; font-size: 14pt; color: #000000;\">Al fine di prevenire la diffusione dell\u2019infezione da Coronavirus SARS-CoV2, visto il perdurare della emergenza pandemica ed in analogia ai termini previsti dal DPCM del 2 marzo 2021, si dispone di prorogare <b>fino al 6 aprile 2021 <\/b>le disposizioni previste dalla precedente nota del 26\/01\/2021 (prot. 0016052).<\/span><\/p>\n<\/div>\n<p style=\"text-align: justify;\"><span style=\"font-family: 'times new roman', times, serif; font-size: 14pt; color: #000000;\">Sono quindi <b>sospesi <\/b>fino a tale data gli incontri degli Informatori Scientifici del Farmaco e dei rappresentanti di dispositivi medici <b>presso tutte le strutture del Servizio sanitario aziendale. <\/b><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">Notwithstanding the above, <\/span><b style=\"color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">access is allowed, only in exceptional cases, upon request from the Director of the OU\/Service and issue of written authorization from the Medical Director of the facility.<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">The information activity can still be carried out using alternative methods remotely.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">For the moment, the provisions communicated with note prot. 86806 of 06\/15\/2020, as regards access to the clinics of general practitioners and family pediatricians and to affiliated pharmacies; please note that these provisions recommend preferring remote activities and allow meetings to be held with informers\/representatives, exclusively in compliance with the rules set out in the aforementioned note.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">These provisions may in any case be subject to modifications, in relation to the evolution of the epidemiological framework and the issuing of further national or local provisions.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-family: 'times new roman', times, serif; font-size: 14pt; color: #000000;\">Recipients are advised to promptly disseminate, within the scope of their competences, the contents of this letter to all UU.OO. and hospital and territorial services, as well as general practitioners and family paediatricians.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-56904\" src=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/03\/APSS-Trento-direttore-San.-firma.jpeg\" alt=\"\" width=\"975\" height=\"1001\" srcset=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/03\/APSS-Trento-direttore-San.-firma.jpeg 975w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/03\/APSS-Trento-direttore-San.-firma-292x300.jpeg 292w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/03\/APSS-Trento-direttore-San.-firma-768x788.jpeg 768w\" sizes=\"auto, (max-width: 975px) 100vw, 975px\" \/><\/p>","protected":false},"excerpt":{"rendered":"<p>Al fine di prevenire la diffusione dell\u2019infezione da Coronavirus SARS-CoV2, visto il perdurare della emergenza pandemica ed in analogia ai termini previsti dal DPCM del 2 marzo 2021, si dispone di prorogare fino al 6 aprile 2021 le disposizioni previste dalla precedente nota del 26\/01\/2021 (prot. 0016052). Sono quindi sospesi fino a tale data gli &hellip;<\/p>","protected":false},"author":4,"featured_media":56906,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[155,21],"class_list":["post-56901","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-primo-piano","tag-divieto-accesso-isf","tag-informatori-scientifici"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/56901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=56901"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/56901\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/56906"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=56901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=56901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=56901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}